About
Contact & Profiles
A5098273666
Research Areas
- Glioma Diagnosis and Treatment
- Brain Metastases and Treatment
- Cancer-related cognitive impairment studies
Burdenko Neurosurgery Institute
2020
Ministry of Health of the Russian Federation
2020
High-dose chemotherapy (HDCT) with autologous hemopoietic stem cell transplantation (auto-HSCT) is currently an integral part of a standard care for younger medulloblastoma (MB) patients and MB relapse. As HDCT regimens are characterized by neurotoxicity, it may add to the one radiation therapy. Therefore, some develop post-irradiation clinical symptoms MRI changes characteristic disease progression, pseudoprogression. We report on case 16-year old patient relapsed treated consequent...
10.21682/2311-1267-2020-7-2-126-33
article
EN
Russian Journal of Pediatric Hematology and Oncology
2020-07-04
Coming Soon ...